Fukuoka, M <br/><br/>
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 1992 
 - 16-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1992.10.1.16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Camptothecin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Diarrhea--chemically induced<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Irinotecan<br/>Leukopenia--chemically induced<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged